Djamel Lebeche

6.3k total citations · 2 hit papers
80 papers, 4.7k citations indexed

About

Djamel Lebeche is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Djamel Lebeche has authored 80 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Cardiology and Cardiovascular Medicine, 42 papers in Molecular Biology and 13 papers in Surgery. Recurrent topics in Djamel Lebeche's work include Cardiomyopathy and Myosin Studies (18 papers), Cardiac electrophysiology and arrhythmias (17 papers) and Cardiac Fibrosis and Remodeling (15 papers). Djamel Lebeche is often cited by papers focused on Cardiomyopathy and Myosin Studies (18 papers), Cardiac electrophysiology and arrhythmias (17 papers) and Cardiac Fibrosis and Remodeling (15 papers). Djamel Lebeche collaborates with scholars based in United States, Japan and France. Djamel Lebeche's co-authors include Roger J. Hajjar, Elie R. Chemaly, Federica del Monte, Wellington V. Cardoso, Judith K. Gwathmey, Soojeong Kang, Shihong Zhang, Yuh-Shin Chang, Mark T. Keating and Shima Arab and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Djamel Lebeche

76 papers receiving 4.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Periostin induces proliferation of differentiated cardiomyocytes and promotes cardiac repair

2007 501 citations Federica del Monte, Roger J. Hajjar et al. profile →
FTO-Dependent N ⁶ -Methyladenosine Regulates Cardiac Function During Remodeling and Repair

2018 452 citations Shihong Zhang, Erik Kohlbrenner et al. Circulation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Djamel Lebeche United States	34	2.8k	1.9k	1.1k	537	476	80	4.7k
Yukio Hiroi Japan	37	3.7k 1.3×	2.0k 1.0×	719 0.7×	278 0.5×	328 0.7×	110	5.4k
Toru Oka Japan	32	2.6k 0.9×	1.9k 1.0×	879 0.8×	339 0.6×	384 0.8×	126	4.4k
Michelle A. Sargent United States	39	4.1k 1.5×	2.3k 1.2×	961 0.9×	408 0.8×	249 0.5×	67	5.9k
Burns C. Blaxall United States	43	3.6k 1.3×	3.2k 1.7×	879 0.8×	519 1.0×	490 1.0×	88	6.3k
Micheline Duriez France	38	2.4k 0.8×	1.4k 0.7×	1.3k 1.2×	510 0.9×	347 0.7×	59	5.6k
Kiyoshi Suzuma Japan	42	2.8k 1.0×	752 0.4×	788 0.8×	539 1.0×	267 0.6×	123	6.8k
Elissavet Kardami Canada	40	3.4k 1.2×	1.3k 0.6×	716 0.7×	294 0.5×	239 0.5×	128	4.7k
Stefan E. Hardt Germany	32	2.1k 0.7×	1.8k 0.9×	711 0.7×	226 0.4×	467 1.0×	91	4.2k
Yong‐Jian Geng United States	40	2.4k 0.8×	846 0.4×	1.6k 1.5×	985 1.8×	542 1.1×	104	5.9k
Brian R. Wamhoff United States	37	3.9k 1.4×	931 0.5×	1.0k 1.0×	1.0k 1.9×	605 1.3×	87	7.1k

Countries citing papers authored by Djamel Lebeche

Since Specialization

Citations

This map shows the geographic impact of Djamel Lebeche's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Djamel Lebeche with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Djamel Lebeche more than expected).

Fields of papers citing papers by Djamel Lebeche

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Djamel Lebeche. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Djamel Lebeche. The network helps show where Djamel Lebeche may publish in the future.

Co-authorship network of co-authors of Djamel Lebeche

This figure shows the co-authorship network connecting the top 25 collaborators of Djamel Lebeche. A scholar is included among the top collaborators of Djamel Lebeche based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Djamel Lebeche. Djamel Lebeche is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Majid, Abdul, et al.. (2025). Nonsense-Mediated mRNA Decay: Mechanisms and Recent Implications in Cardiovascular Diseases. Cells. 14(16). 1283–1283. 1 indexed citations

Kang, Soojeong, Abdul Majid, Nadjib Hammoudi, & Djamel Lebeche. (2025). Gene and drug-mediated SERCA2a activation restores cardiac function and metabolic balance in diabetic mice. Biomedicine & Pharmacotherapy. 192. 118617–118617.

Bajpai, Akhilesh Kumar, Yufeng Chen, David G. Ashbrook, et al.. (2023). Expression Levels of the Tnni3k Gene in the Heart Are Highly Associated with Cardiac and Glucose Metabolism-Related Phenotypes and Functional Pathways. International Journal of Molecular Sciences. 24(16). 12759–12759. 5 indexed citations

Majid, Abdul, et al.. (2023). Bioactive Compounds and Cardiac Fibrosis: Current Insight and Future Prospect. Journal of Cardiovascular Development and Disease. 10(7). 313–313. 6 indexed citations

Singh, Rajvir, et al.. (2021). Resistin induces cardiac fibroblast-myofibroblast differentiation through JAK/STAT3 and JNK/c-Jun signaling. Pharmacological Research. 167. 105414–105414. 61 indexed citations

Hammoudi, Nadjib, Dongtak Jeong, Rajvir Singh, et al.. (2017). Empagliflozin Improves Left Ventricular Diastolic Dysfunction in a Genetic Model of Type 2 Diabetes. Cardiovascular Drugs and Therapy. 31(3). 233–246. 121 indexed citations

Cai, Wenfeng, Guan‐Sheng Liu, Chi Keung Lam, et al.. (2015). Up-Regulation of Micro-RNA765 in Human Failing Hearts is Associated with Post-Transcriptional Regulation of Protein Phosphatase Inhibitor-1 and Depressed Contractility. European Journal of Heart Failure. 17(8). 782–793. 19 indexed citations

Chemaly, Elie R., Soojeong Kang, Shihong Zhang, et al.. (2013). Differential patterns of replacement and reactive fibrosis in pressure and volume overload are related to the propensity for ischaemia and involve resistin. The Journal of Physiology. 591(21). 5337–5355. 30 indexed citations

Mahoney, Christopher E., Diane E. Handy, Kevin P. White, et al.. (2012). Bone Morphogenetic Protein‐2 Decreases MicroRNA‐30b and MicroRNA‐30c to Promote Vascular Smooth Muscle Cell Calcification. Journal of the American Heart Association. 1(6). e003905–e003905. 115 indexed citations

10.

Chemaly, Elie R., Lahouaria Hadri, Shihong Zhang, et al.. (2011). Long-term in vivo resistin overexpression induces myocardial dysfunction and remodeling in rats. Journal of Molecular and Cellular Cardiology. 51(2). 144–155. 69 indexed citations

11.

Hadri, Lahouaria, Régis Bobe, Yoshiaki Kawase, et al.. (2010). SERCA2a Gene Transfer Enhances eNOS Expression and Activity in Endothelial Cells. Molecular Therapy. 18(7). 1284–1292. 54 indexed citations

12.

Jin, Hongwei, Lahouaria Hadri, Julieta Palomeque, et al.. (2010). KChIP2 attenuates cardiac hypertrophy through regulation of Ito and intracellular calcium signaling. Journal of Molecular and Cellular Cardiology. 48(6). 1169–1179. 32 indexed citations

13.

Poller, Wolfgang, Lennart Suckau, Henry Fechner, et al.. (2008). Abstract 3807: Chronic Cardiac-Targeted RNA Interference for the Treatment of Severe Heart Failure Restores Cardiac Function and Reduces Pathological Hypertrophy. Circulation. 118. 1 indexed citations

14.

Kawase, Yoshiaki, Hung Q. Ly, Fabrice Prunier, et al.. (2008). Reversal of Cardiac Dysfunction After Long-Term Expression of SERCA2a by Gene Transfer in a Pre-Clinical Model of Heart Failure. Journal of the American College of Cardiology. 51(11). 1112–1119. 261 indexed citations

15.

Kim, Maengjo, et al.. (2008). Role of resistin in cardiac contractility and hypertrophy. Journal of Molecular and Cellular Cardiology. 45(2). 270–280. 133 indexed citations

16.

Sakata, Susumu, Lifan Liang, Elie R. Chemaly, et al.. (2007). PRESERVATION OF MECHANICAL AND ENERGETIC FUNCTION AFTER ADENOVIRAL GENE TRANSFER IN NORMAL RAT HEARTS. Clinical and Experimental Pharmacology and Physiology. 34(12). 1300–1306. 8 indexed citations

17.

Ly, Hung Q., Yoshiaki Kawase, Djamel Lebeche, et al.. (2007). Abstract 321: Cardiac Function Improvement Following In vivo Intracoronary Adeno-Associated Virus Type 1 Vector Gene Transfer of SERCA2a in a Pre-Clinical Model of Heart Failure. Circulation. 116(suppl_16). 1 indexed citations

18.

Sakata, Susumu, Djamel Lebeche, Elie R. Chemaly, et al.. (2006). Transcoronary gene transfer of SERCA2a increases coronary blood flow and decreases cardiomyocyte size in a Type 2 diabetic rat model. American Journal of Physiology-Heart and Circulatory Physiology. 292(2). H1204–H1207. 54 indexed citations

19.

Lebeche, Djamel, et al.. (2005). Transgenic Models of Heart Failure: Elucidation of the Molecular Mechanisms of Heart Disease. Heart Failure Clinics. 1(2). 219–236. 3 indexed citations

20.

Lebeche, Djamel, et al.. (1999). Fibroblast growth factor interactions in the developing lung. Mechanisms of Development. 86(1-2). 125–136. 197 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact